Risk factors for subarachnoid haemorrhage: a nationwide cohort of 950 000 adults.


Journal

International journal of epidemiology
ISSN: 1464-3685
Titre abrégé: Int J Epidemiol
Pays: England
ID NLM: 7802871

Informations de publication

Date de publication:
01 12 2019
Historique:
accepted: 11 07 2019
pubmed: 1 8 2019
medline: 16 7 2020
entrez: 1 8 2019
Statut: ppublish

Résumé

Subarachnoid haemorrhage (SAH) is a devastating disease, with high mortality rate and substantial disability among survivors. Its causes are poorly understood. We aimed to investigate risk factors for SAH using a novel nationwide cohort consortium. We obtained individual participant data of 949 683 persons (330 334 women) between 25 and 90 years old, with no history of SAH at baseline, from 21 population-based cohorts. Outcomes were obtained from the Swedish Patient and Causes of Death Registries. During 13 704 959 person-years of follow-up, 2659 cases of first-ever fatal or non-fatal SAH occurred, with an age-standardized incidence rate of 9.0 [95% confidence interval (CI) (7.4-10.6)/100 000 person-years] in men and 13.8 [(11.4-16.2)/100 000 person-years] in women. The incidence rate increased exponentially with higher age. In multivariable-adjusted Poisson models, marked sex interactions for current smoking and body mass index (BMI) were observed. Current smoking conferred a rate ratio (RR) of 2.24 (95% CI 1.95-2.57) in women and 1.62 (1.47-1.79) in men. One standard deviation higher BMI was associated with an RR of 0.86 (0.81-0.92) in women and 1.02 (0.96-1.08) in men. Higher blood pressure and lower education level were also associated with higher risk of SAH. The risk of SAH is 45% higher in women than in men, with substantial sex differences in risk factor strengths. In particular, a markedly stronger adverse effect of smoking in women may motivate targeted public health initiatives.

Sections du résumé

BACKGROUND
Subarachnoid haemorrhage (SAH) is a devastating disease, with high mortality rate and substantial disability among survivors. Its causes are poorly understood. We aimed to investigate risk factors for SAH using a novel nationwide cohort consortium.
METHODS
We obtained individual participant data of 949 683 persons (330 334 women) between 25 and 90 years old, with no history of SAH at baseline, from 21 population-based cohorts. Outcomes were obtained from the Swedish Patient and Causes of Death Registries.
RESULTS
During 13 704 959 person-years of follow-up, 2659 cases of first-ever fatal or non-fatal SAH occurred, with an age-standardized incidence rate of 9.0 [95% confidence interval (CI) (7.4-10.6)/100 000 person-years] in men and 13.8 [(11.4-16.2)/100 000 person-years] in women. The incidence rate increased exponentially with higher age. In multivariable-adjusted Poisson models, marked sex interactions for current smoking and body mass index (BMI) were observed. Current smoking conferred a rate ratio (RR) of 2.24 (95% CI 1.95-2.57) in women and 1.62 (1.47-1.79) in men. One standard deviation higher BMI was associated with an RR of 0.86 (0.81-0.92) in women and 1.02 (0.96-1.08) in men. Higher blood pressure and lower education level were also associated with higher risk of SAH.
CONCLUSIONS
The risk of SAH is 45% higher in women than in men, with substantial sex differences in risk factor strengths. In particular, a markedly stronger adverse effect of smoking in women may motivate targeted public health initiatives.

Identifiants

pubmed: 31363756
pii: 5541045
doi: 10.1093/ije/dyz163
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2018-2025

Informations de copyright

© The Author(s) 2019; all rights reserved. Published by Oxford University Press on behalf of the International Epidemiological Association.

Auteurs

Johan Sundström (J)

Department of Medical Sciences, Uppsala University, Uppsala, Sweden.
George Institute for Global Health, University of New South Wales, Sydney, NSW, Australia.

Martin Söderholm (M)

Department of Clinical Sciences, Lund University, Lund, Sweden.

Stefan Söderberg (S)

Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden.

Lars Alfredsson (L)

Institute of Environmental Medicine, Cardiovascular Epidemiology, Karolinska Institutet, Stockholm, Sweden.

Martin Andersson (M)

Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden.

Rino Bellocco (R)

Department of Statistics and Quantitative Methods, University of Milano-Biocca, Milan, Italy.
Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.

Martin Björck (M)

Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.

Per Broberg (P)

Department of Clinical Sciences, Cancer Epidemiology, Lund University, Lund, Sweden.

Maria Eriksson (M)

Department of Neurosurgery, Umeå University, Umeå, Sweden.

Marie Eriksson (M)

Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden.
Department of Statistics, Umeå University, Umeå, Sweden.

Bertil Forsberg (B)

Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden.

Eleonor I Fransson (EI)

Department of Natural Science and Biomedicine, School of Health and Welfare, Jönköping University, Jönköping, Sweden.

Vilmantas Giedraitis (V)

Department of Public Health and Caring Sciences, Uppsala University, Uppsala, Sweden.

Jenny Theorell-Haglöw (J)

Department of Medical Sciences, Uppsala University, Uppsala, Sweden.

Johan Hallqvist (J)

Department of Public Health and Caring Sciences, Uppsala University, Uppsala, Sweden.

Per-Olof Hansson (PO)

Department of Molecular and Clinical Medicine, Sahlgrenska Academy/ Sahlgrenska University Hospital, University of Gothenburg, Gothenburg, Sweden.

Susanne Heller (S)

Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden.

Niclas Håkansson (N)

Unit of Nutritional Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.

Martin Ingelsson (M)

Department of Public Health and Caring Sciences, Uppsala University, Uppsala, Sweden.

Christer Janson (C)

Department of Medical Sciences, Uppsala University, Uppsala, Sweden.

Bengt Järvholm (B)

Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden.

Payam Khalili (P)

Department of Cardiology and Acute Internal Medicine, Central Hospital, Karlstad, Sweden.

Anders Knutsson (A)

Department of Health Sciences, Mid Sweden University, Ostersund, Sweden.

Anton Lager (A)

Centre for Epidemiology and Community Medicine, Stockholm County Council, Stockholm, Sweden.
Department of Public Health Sciences, Stockholm, Sweden.

Ylva Trolle Lagerros (YT)

Clinical Epidemiology Unit, Department of Medicine, Karolinska Institutet, Stockholm, Sweden.
Department of Medicine, Karolinska University Hospital, Huddinge, Stockholm, Sweden.

Susanna C Larsson (SC)

Unit of Nutritional Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.

Karin Leander (K)

Institute of Environmental Medicine, Cardiovascular Epidemiology, Karolinska Institutet, Stockholm, Sweden.

Jerzy Leppert (J)

Centre for Clinical Research Västerås, Västmanland Region, and Uppsala University, Västerås, Sweden.

Lars Lind (L)

Department of Medical Sciences, Uppsala University, Uppsala, Sweden.

Eva Lindberg (E)

Department of Medical Sciences, Uppsala University, Uppsala, Sweden.

Cecilia Magnusson (C)

Centre for Epidemiology and Community Medicine, Stockholm County Council, Stockholm, Sweden.
Department of Public Health Sciences, Stockholm, Sweden.

Patrik K E Magnusson (PKE)

Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.

Mauricio Malfert (M)

Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden.

Karl Michaëlsson (K)

Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.

Peter Nilsson (P)

Department of Clinical Sciences, Lund University, Lund, Sweden.

Håkan Olsson (H)

Department of Clinical Sciences, Cancer Epidemiology, Lund University, Lund, Sweden.

Nancy L Pedersen (NL)

Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.

Johanna Pennlert (J)

Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden.

Andreas Rosenblad (A)

Centre for Clinical Research Västerås, Västmanland Region, and Uppsala University, Västerås, Sweden.

Annika Rosengren (A)

Department of Molecular and Clinical Medicine, Sahlgrenska Academy/ Sahlgrenska University Hospital, University of Gothenburg, Gothenburg, Sweden.

Kjell Torén (K)

Section of Occupational and Environmental Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.

Anders Wanhainen (A)

Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.

Alicja Wolk (A)

Unit of Nutritional Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.

Gunnar Engström (G)

Department of Clinical Sciences, Lund University, Lund, Sweden.

Bodil Svennblad (B)

Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.

Bernice Wiberg (B)

Department of Public Health and Caring Sciences, Uppsala University, Uppsala, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH